Drugs / Influenza Virus Vaccine, Monovalent A/H5N1 A/Indonesia/05/2005
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01086566 | Oct 2010 → Feb 2012 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza Virus Vaccine, Monovalent A/H5N1 A/Indonesia/05/2005 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01086566 ↗ |
| Known as | A/Indonesia/5/05 | “Primed subjects are randomized to receive a single dose of either 15 mcg or 90 mcg of A/Indonesia/5/05 vaccine.” NCT01086566 ↗ |
| Modality | Vaccine | “Inactivated monovalent subvirion H5N1 vaccine” NCT01086566 ↗ |